Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

PI Controller: Design01:24

PI Controller: Design

1.6K
Proportional Integral (PI) controllers are a fundamental component in modern control systems, widely used to enhance performance and mitigate steady-state errors. They are particularly effective in applications such as automatic brightness adjustment on smartphones, where they excel at mitigating steady-state errors for step-function inputs. Unlike PD controllers, which require time-varying errors to function optimally, PI controllers leverage their integral component to address residual...
1.6K
PD Controller: Design01:26

PD Controller: Design

761
In automotive engineering, car suspension systems often employ Proportional Derivative (PD) controllers to enhance performance. PD controllers are utilized to adjust the damping force in response to road conditions. A controller, acting as an amplifier with a constant gain, demonstrates proportional control, with output directly mirroring input.
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
761
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

159
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
159
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

97
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

563
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
563
Time and frequency -Domain Interpretation of PI Control01:27

Time and frequency -Domain Interpretation of PI Control

503
Proportional-Integral (PI) controllers are essential in many control systems to improve stability and performance. They are commonly used in everyday devices like thermostats to enhance system damping and reduce steady-state error. When the zero in the controller's transfer function is optimally placed, the system benefits significantly in terms of stability and accuracy.
Acting as a low-pass filter, the PI controller slows the system's response and extends settling times. This requires...
503

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Machine Learning Prediction of Growth Hormone Response in Children Non-Growth Hormone-Deficient Short Stature.

Studies in health technology and informatics·2026
Same author

A hierarchical network model for the estimate of the energy expenditure in individuals with type 1 diabetes.

Engineering applications of artificial intelligence·2026
Same author

Research Code Sharing in Support of Gold Standard Science.

Journal of diabetes science and technology·2026
Same author

Postprandial Glucagon Metabolism in Healthy and Type 1 Diabetes.

Diabetes·2025
Same author

Funnel-based antimicrobial resistance monitoring in Italy: the FUN-IT study.

Scientific reports·2025
Same author

Improvement in Insulin Sensitivity Prevents Decline in Glucose Uptake, Functional Connectivity, and Volume in the Insulin Resistant Human Brain.

Research square·2025

Related Experiment Video

Updated: May 4, 2026

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

14.9K

Artificial pancreas: model predictive control design from clinical experience.

Chiara Toffanin1, Mirko Messori, Federico Di Palma

  • 1Department of Civil Engineering and Architecture, University of Pavia, Pavia, Italy.

Journal of Diabetes Science and Technology
|December 20, 2013
PubMed
Summary

This study introduces an advanced artificial pancreas using model predictive control (MPC) to lower mean glucose levels in type 1 diabetes patients. The new system demonstrates promising results, enhancing safety and paving the way for extended outpatient use.

More Related Videos

An Orthotopic Resectional Mouse Model of Pancreatic Cancer
07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

11.2K
A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination
12:33

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination

Published on: June 25, 2014

64.9K

Related Experiment Videos

Last Updated: May 4, 2026

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

14.9K
An Orthotopic Resectional Mouse Model of Pancreatic Cancer
07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

11.2K
A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination
12:33

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination

Published on: June 25, 2014

64.9K

Area of Science:

  • Biomedical Engineering
  • Control Systems Engineering
  • Endocrinology

Background:

  • Leverages over 5000 hours of clinical closed-loop control experience.
  • Addresses the need for improved artificial pancreas systems in type 1 diabetes management.
  • Builds upon previous research from AP@home and JDRF projects.

Purpose of the Study:

  • To develop a novel artificial pancreas controller.
  • To reduce mean glucose levels while minimizing hypoglycemia.
  • To enhance the safety and efficacy of artificial pancreas systems for outpatient use.

Main Methods:

  • Developed a new sensor model using AP@home trial data.
  • Tuned a Kalman filter within the controller using clinical data.
  • Incorporated critical clinical constraints (e.g., pump shutoff) into the model predictive control (MPC).
  • Tested the MPC on a virtual population using the University of Virginia/Padova simulator.

Main Results:

  • The MPC demonstrated promising results in reducing mean glucose levels.
  • Analysis showed a favorable number of patients within the target glucose range.
  • Preliminary outpatient pilot trials yielded encouraging outcomes.

Conclusions:

  • The proposed MPC outperforms previous controllers in artificial pancreas systems.
  • The algorithm, with a safety module, is a significant advancement for long-term outpatient deployment.
  • This technology represents a crucial step toward widespread adoption of artificial pancreases.